Vivoryon Therapeutics NV
AEX:VVY
Vivoryon Therapeutics NV
AEX:VVY
Price:
1.29
EUR
-1.68%
Market Closed
Market Cap:
€38.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vivoryon Therapeutics NV
AEX:VVY
|
DE |
|
Yang Ming Marine Transport Corp
TWSE:2609
|
TW |
|
H
|
Haoxin Holdings Ltd
NASDAQ:HXHX
|
CN |
|
Is Gayrimenkul Yatirim Ortakligi AS
IST:ISGYO.E
|
TR |
|
Compass Group PLC
LSE:CPG
|
UK |
|
Tirupati Tyres Ltd
BSE:539040
|
IN |
|
IGB Eletronica SA
BOVESPA:IGBR3
|
BR |
|
A
|
APR Co Ltd
KRX:278470
|
KR |
Relative Value
The Relative Value of one
VVY
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 1.29 EUR,
Vivoryon Therapeutics NV
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VVY Relative Value
HIDDEN
Multiples Across Competitors
VVY Competitors Multiples
Vivoryon Therapeutics NV Competitors
Vivoryon Therapeutics NV Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Vivoryon Therapeutics NV
AEX:VVY
|
38.2m EUR | 0 | -3.1 | -2.7 | -2.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.5 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.5 | 29 | 21.8 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.6B USD | 10.9 | 129.6 | 72.5 | 80.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
